Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ephedrine as add-on therapy for patients with myasthenia gravis
2014-001355-23Phase 2Active
- Sponsor
- Leiden University Medical Center
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myasthenia gravis (MG) comparing Ephedrine add-on arm with Placebo add-on arm (2 arms). Primary endpoint: Primary efficacy of add-on ephedrine. Started May 2014; status: active.
02
Drugs
ephedrine
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on 2014-001355-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001355-23.